A recent article on yahoo!news painted a highly complicated picture of how patients and doctors in the U.S. are trying to negotiate their way through the new field of advanced drugs that promote weight loss.
The article quotes an obesity medicine specialist at Massachusetts General Hospital and Harvard Medical School, saying “Access to medicines for the treatment of obesity is dismal in this country”. This is even though leading pharmaceutical companies have recently developed significant new streams of medication.
The difficulties are both in getting a higher level of adoption of the drugs by prescribing physicians and gaining acceptance of these drugs as essential treatments by healthcare funds.Â
Up to now, the treatment of obesity has not been seen as a high-demand field of specialization within the medical profession, despite more than forty percent of adult Americans being clinically obese, according to the National Institute of Diabetes Digestive and Kidney Diseases.Â
Obesity may be the biggest chronic medical problem in the population. Still, fewer than one in one hundred doctors in the U.S. are trained as obesity specialists. It also spills over into general practice, because many doctors
are not used to recognizing and treating the causes and symptoms. There still remains a general feeling that obesity is a sign of weakness of character and that the way to correct it is for the person suffering to “pull themselves up by their bootstraps and try harder.” Many doctors think that drugs for weight loss are unsafe, and that patients will eventually regain whatever weight they have lost anyway.
Dr. Scott Kahan, an obesity medicine specialist in Washington, D.C. adds that this is a perception many patients share. Hence, they are reluctant to seek medical advice.
One mother’s experience of perinatal mood and anxiety disorder
When “fear of the unknown” is mentioned as a main trigger for postpartum depression and perinatal mood and anxiety disorder
Read More »